Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...
People with deadly allergies could receive life saving treatment without a needle from a groundbreaking medical device ...
17h
GB News on MSNProduct recall: Garlic powders sold in the UK could be 'life-threatening' to some consumersA recall has been issued for several spices that pose a health risk to consumers with a food allergen. Damasgate Wholesale is ...
6h
Health on MSNWhat Causes Bumps on Your Tongue?Medically reviewed by Steffini Stalos, DO There are many reasons you can develop bumps on your tongue. Often, these growths ...
The bill (LB135) from Sen. Rick Holdcroft of Bellevue would require school districts to only put bond issues before voters ...
The biosimilar was not approved for other forms of urticaria, nor for acute or emergency treatment of bronchospasm, status asthmaticus, or allergic reactions like anaphylaxis. The approval was ...
The main symptom of chickenpox is an itchy, spotty rash that can be anywhere on the body. Chickenpox happens in three stages, ...
From cognitive enhancement to mood support and increased energy levels, methylene blue has gained popularity for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results